[go: up one dir, main page]

NO971110D0 - Fremgangsmåte for fremstilling av en modifisert, kollagenindusert blodplateaggregeringsinhibitor, pallidipin - Google Patents

Fremgangsmåte for fremstilling av en modifisert, kollagenindusert blodplateaggregeringsinhibitor, pallidipin

Info

Publication number
NO971110D0
NO971110D0 NO971110A NO971110A NO971110D0 NO 971110 D0 NO971110 D0 NO 971110D0 NO 971110 A NO971110 A NO 971110A NO 971110 A NO971110 A NO 971110A NO 971110 D0 NO971110 D0 NO 971110D0
Authority
NO
Norway
Prior art keywords
pallidipine
preparation
platelet aggregation
aggregation inhibitor
induced platelet
Prior art date
Application number
NO971110A
Other languages
English (en)
Other versions
NO971110L (no
Inventor
Christiane Noeske-Jungblut
Andreas Becker
Bernard Haendler
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO971110D0 publication Critical patent/NO971110D0/no
Publication of NO971110L publication Critical patent/NO971110L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO971110A 1994-09-12 1997-03-11 Fremgangsmåte for fremstilling av en modifisert, kollagenindusert blodplateaggregeringsinhibitor, pallidipin NO971110L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94250224 1994-09-12
PCT/EP1995/003573 WO1996008563A1 (en) 1994-09-12 1995-09-11 Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin

Publications (2)

Publication Number Publication Date
NO971110D0 true NO971110D0 (no) 1997-03-11
NO971110L NO971110L (no) 1997-05-07

Family

ID=8217517

Family Applications (1)

Application Number Title Priority Date Filing Date
NO971110A NO971110L (no) 1994-09-12 1997-03-11 Fremgangsmåte for fremstilling av en modifisert, kollagenindusert blodplateaggregeringsinhibitor, pallidipin

Country Status (22)

Country Link
US (1) US5882887A (no)
EP (1) EP0781334A1 (no)
JP (1) JPH10505502A (no)
CN (1) CN1075836C (no)
AU (1) AU701643B2 (no)
BG (1) BG63276B1 (no)
BR (1) BR9508910A (no)
CA (1) CA2199719A1 (no)
CZ (1) CZ76297A3 (no)
FI (1) FI971013A7 (no)
HU (1) HU222398B1 (no)
IL (1) IL115272A0 (no)
MX (1) MX9701720A (no)
NO (1) NO971110L (no)
NZ (1) NZ293261A (no)
PL (1) PL184617B1 (no)
RO (1) RO117971B1 (no)
RU (1) RU2186110C2 (no)
SI (1) SI9520093A (no)
SK (1) SK29297A3 (no)
WO (1) WO1996008563A1 (no)
ZA (1) ZA957649B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL200384B1 (pl) * 1999-03-18 2008-12-31 Merck Patent Gmbh Polipeptyd blokujący adhezję płytek krwi, sposób jego otrzymywania, zastosowanie i zawierający go preparat farmaceutyczny
EP1831395A1 (en) * 2004-12-28 2007-09-12 Ares Trading S.A. Compositions and methods for treating schizophrenia and related disorders
US7691839B2 (en) 2005-09-28 2010-04-06 Biovascular, Inc. Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammation
US20110034396A1 (en) * 2005-09-28 2011-02-10 Biovascular, Inc. Methods and compositions for inhibiting cell migration and treatment of inflammatory conditions
TWI391143B (zh) * 2005-11-04 2013-04-01 Otsuka Pharma Co Ltd 血小板凝集抑制劑組成物
US9617302B2 (en) * 2011-06-14 2017-04-11 National Taiwan University Peptide compounds for inhibition of platelet aggregation
FR2979346B1 (fr) 2011-08-23 2013-09-27 Univ Joseph Fourier Nanocorps anti-vcam-1
EP2812012A1 (en) 2012-02-07 2014-12-17 Global Bio Therapeutics USA, Inc. Compartmentalized method of nucleic acid delivery and compositions and uses thereof
NZ705899A (en) 2012-09-07 2018-08-31 Inst Nat Sante Rech Med Inhibiting peptides derived from triggering receptor expressed on myeloid cells-1 (trem-1) trem-like transcript 1 (tlt-1) and uses thereof
MX378673B (es) 2013-08-08 2025-03-10 Global Bio Therapeutics Inc Dispositivo de sujecion para procedimientos minimamente invasivos y usos del mismo.
FR3058143B1 (fr) 2016-10-27 2021-03-12 Univ Grenoble Alpes Nanocorps anti-tau
EP4340855A1 (en) 2021-08-13 2024-03-27 Triovance Holding LLC A skin substitute composition and methods of producing and using the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03503596A (ja) * 1987-06-24 1991-08-15 ノボ・ノルディスク エー/エス 蛋白質若しくはポリペプチドの調製方法、該ポリペプチドをコードするdna配列、該dna配列およびポリペプチドを有する微生物および該ポリペプチドの薬学的製剤としての利用
RU2128705C1 (ru) * 1991-09-05 1999-04-10 Шеринг Аг Протеин, ингибирующий вызываемую коллагеном агрегацию тромбоцитов млекопитающих, рекомбинантный протеин, ингибирующий вызываемую коллагеном агрегацию тромбоцитов, фрагмент днк, кодирующий рекомбинантный протеин, вектор экспрессии (варианты), штамм культивируемых животных клеток внк - продуцент рекомбинантного протеина (варианты), способ получения рекомбинантного протеина, фармацевтическая композиция
US5756454A (en) * 1991-09-05 1998-05-26 Schering Aktiengesellschaft Collagen-induced platelet aggregation inhibitor
US5705362A (en) * 1992-05-25 1998-01-06 Gist-Brocades, N.V. Modified signal sequences

Also Published As

Publication number Publication date
NO971110L (no) 1997-05-07
PL184617B1 (pl) 2002-11-29
FI971013A0 (fi) 1997-03-11
WO1996008563A1 (en) 1996-03-21
AU701643B2 (en) 1999-02-04
HUT76972A (hu) 1998-01-28
JPH10505502A (ja) 1998-06-02
HU222398B1 (hu) 2003-06-28
SK29297A3 (en) 1997-10-08
CA2199719A1 (en) 1996-03-21
CZ76297A3 (cs) 1998-01-14
BR9508910A (pt) 1997-10-28
FI971013A7 (fi) 1997-03-11
EP0781334A1 (en) 1997-07-02
PL319078A1 (en) 1997-07-21
IL115272A0 (en) 1995-12-31
RU2186110C2 (ru) 2002-07-27
MX9701720A (es) 1997-06-28
SI9520093A (en) 1997-08-31
BG63276B1 (bg) 2001-08-31
CN1159828A (zh) 1997-09-17
CN1075836C (zh) 2001-12-05
NZ293261A (en) 1998-11-25
BG101226A (bg) 1998-10-30
US5882887A (en) 1999-03-16
ZA957649B (en) 1996-04-15
RO117971B1 (ro) 2002-11-29
AU3565795A (en) 1996-03-29

Similar Documents

Publication Publication Date Title
IS4647A (is) Nýir hemlar á samsöfnun blóðflagna
ATE283264T1 (de) Zwischenprodukte zur herstellung von metallproteinasehemmern
EE03485B1 (et) Protsess asendatud sulfinüülheterotsükli magneesiumisoola valmistamiseks
EE03342B1 (et) Suitsetamistarvete pakend
EE9800065A (et) 5-O-desosaminüül-6-O-metüülerütronoliid A uued derivaadid, nende valmistamismeetod ja kasutamine bioaktiivsete produktide valmistamiseks
FI973281L (fi) Menetelmä tiettyjen atsasykloheksapeptidien valmistamiseksi
NO971110D0 (no) Fremgangsmåte for fremstilling av en modifisert, kollagenindusert blodplateaggregeringsinhibitor, pallidipin
NO982237D0 (no) Ny fremgangsmÕte for fremstilling av fenylimidazolidinderivater
EE9800109A (et) 5-O-desosaminüül-6-O-metüülerütronoliid A uued derivaadid, nende valmistamismeetod ja kasutamine bioaktiivsete produktide valmistamiseks
NO972402D0 (no) Fremgangsmåte for fremstilling av bærere
NO306817B1 (no) Fremgangsmåte for fremstilling av aluminoksaner
FI970564L (fi) Uusi menetelmä di-isopinokamfeyyliklooriboraanin valmistamiseksi
FI973644A0 (fi) Uusi menetelmä 2,3-dihydrobentsofuranolijohdannaisten valmistamiseksi
NO940171L (no) Fremgangsmåte for kontinuerlig fremstilling av dimetoksyetanal
FI956058A0 (fi) Menetelmä glutaaridialdehydin valmistamiseksi
BR9603088A (pt) Produto embalado
FI954749L (fi) Uusi menetelmä klonidiinijohdannaisten valmistamiseksi
FI972694A0 (fi) Uusi menetelmä sameridiinin valmistamiseksi
NO20062796L (no) Fremgangsmate for fremstilling av en dihydroksyaminoforbindelse
NO972129D0 (no) Fremgangsmåte for fremstilling av 1-halo-3-trialkylsilanyl-benzenderivater
FI956236A7 (fi) Uusi menetelmä 17 beta-substituoitujen 4-atsa-androstaanijohdannaisten valmistamiseksi
NO964519D0 (no) Fremgangsmåte for fremstilling av chitosanalkylderivater
FI953320A7 (fi) Menetelmä 4-alkyyli-2-hydroksi-3,5-diklooribentseenisulfonihappojen valmistamiseksi
DE69520189D1 (de) Entfernung von Adsorbat
FI20040505A7 (fi) Menetelmä 1,3-dihydro-6-hydroksi-2H-indol-2-oni-johdannaisten valmistamiseksi